CD21lo B cells isolated from rheumatic disease patients upregulate costimulatory molecules and drive CD69 upregulation on T cells, suggesting CD21lo B cells are competent to present antigen to T cells [29]. The gene discussed is CD69; the disease is rheumatic disorder.